NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
Tommy Weiss‐Sadan(Hebrew University of Jerusalem), Liron Bar‐Peled(Massachusetts General Hospital), Tzu-Yi Yang, Hannah Fischer, Marianne Richter, Magdy Gohar(Massachusetts General Hospital), Junbing Zhang(Massachusetts General Hospital), Ting-Yu Wei(Massachusetts General Hospital), Adriaan de Groot(Massachusetts General Hospital), Charles H. Adelmann(The University of Texas MD Anderson Cancer Center), Benedikt R. Dürr(Massachusetts General Hospital), Konstantin Wolf, Marcia C. Haigis(Harvard University), Mariko Takahashi(University of Michigan), Maolin Ge(Shanghai Jiao Tong University), Cong-Hui Yao(University of Chicago), Tristan Vornbäumen(Massachusetts General Hospital), Thales Papagiannakopoulos(NYU Langone Health), Vindhya Vijay(Broad Institute), Raúl Mostoslavsky(Broad Institute), Alexander Carlin(Massachusetts General Hospital), David E. Fisher(Massachusetts General Hospital), Lei Shi(China Pharmaceutical University), Aaron N. Hata(Harvard University), Stefan Harry(Massachusetts General Hospital), Nabeel Bardeesy(Broad Institute), Makiko Hayashi(NYU Langone Health)
Cited by 21
Related Papers
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
|Nature|2005|1.5k
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
|Clinical Cancer Research|2016|1.2k
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
|Signal Transduction and Targeted Therapy|2023|1.2k